AC
BLFS icon

Allstate Corporation’s BioLife Solutions BLFS Stock Holding History

Allstate Corporation’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$547K Buy
+19,357
New +$452K 0.01% 990

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allstate Corporation's BLFS Position: Q2 2026 in Review

Allstate Corporation opened a new position in BioLife Solutions (BLFS) in Q2 2026: 19,357 shares worth $547K. The stake represents 0.01% of the portfolio and ranks #990 among its holdings.

216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Allstate Corporation held 19,357 shares of BioLife Solutions worth $547K as of Q2 2026.
  • BioLife Solutions was a new Allstate Corporation position in Q2 2026.
  • BioLife Solutions made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #990 holding.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.